Business News • PR NewsWire • Novartis Drug Afinitor® Approved by FDA as First Medication for Children and Adults with a Benign Brain Tumor Associated with Tuberous Sclerosis

Novartis Drug Afinitor® Approved by FDA as First Medication for Children and Adults with a Benign Brain Tumor Associated with Tuberous Sclerosis

Novartis Drug Afinitor® Approved by FDA as First Medication for Children and Adults with a Benign Brain Tumor Associated with Tuberous Sclerosis

EAST HANOVER, N.J., Oct. 29 /PRNewswire/ -- Novartis Pharmaceuticals Corporation ("Novartis") announced today that the U.S. Food and Drug Administration (FDA) has approved Afinitor® (everolimus) tablets for patients with subependymal giant cell astrocytoma (SEGA), a benign brain tumor associate

View More : http://www.prnewswire.com/news-releases/novartis-drug-afinitor-approved-by-fda-as-first-medication-for-children-and-adul...

Releted News by prnewswire

Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2011